Motley Fool Premium
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (TSX: BHC)
    3. /

TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: This Risky Stock Has Huge Upside

    | Nelson Smith

    After falling 90%, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been written off for dead. But perhaps value investors might want…

    Read more »

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Hit the Bottom Yet?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have lost over 90% in value over the past year, but the company continues…

    Read more »

    The Motley Fool
    Investing

    What Can Investors Expect From Valeant Pharmaceuticals Intl Inc.?

    | Jacob Donnelly

    Because of high debt, a money-losing partnership, and questions about whether or not insiders have faith, I say avoid Valeant…

    Read more »

    The Motley Fool
    Investing

    How Valeant Pharmaceuticals Intl Inc. Could Become a Great Investment

    | Demetris Afxentiou

    Beleaguered Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is starting to make amends for the epic collapse of the stock over the…

    Read more »

    Investing

    3 Companies Actually Investing in the Future

    | Will Ashworth

    While analysts at the Bank of Canada and big banks such as Canadian Imperial Bank of Commerce (TSX:CM)(NYSE:CM) are seeing…

    Read more »

    The Motley Fool
    Dividend Stocks

    Brexit: 4 Negative Effects on the Stock Market

    | Kay Ng

    The Brexit added volatility to the stock market, but selective groups of stocks are more vulnerable to declines, including cyclical…

    Read more »

    The Motley Fool
    Investing

    Can Investors Expect Anything Good From Valeant Pharmaceuticals Intl Inc.?

    | Jacob Donnelly

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) won't default, it needs to show that it can be profitable and pay down…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Recover?

    | Demetris Afxentiou

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) tumbled this week on reports that it cut 2016 profit forecasts, prompting investors…

    Read more »

    The Motley Fool
    Investing

    3 TSX Stocks That Are Down but Not out

    | Will Ashworth

    There are 32 TSX stocks down at least 5% year-to-date, including Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), which is off a…

    Read more »

    The Motley Fool
    Investing

    Has the Worst Passed for Valeant Pharmaceuticals Intl Inc.?

    | Demetris Afxentiou

    After what can only be described as an epic collapse, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:NRX) may have turned the first…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is It Going to Default?

    | Jacob Donnelly

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) received a default notice, I expect it to be just fine, and it might…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Cleans Shop. Is it a Buy Now?

    | Jacob Donnelly

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is looking to turn around with operational changes. However, it's not a buy until it…

    Read more »